Published in Proc Natl Acad Sci U S A on January 01, 1990
How clonal is Staphylococcus aureus? J Bacteriol (2003) 7.97
Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun (2002) 7.34
Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc Natl Acad Sci U S A (2001) 6.22
Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination. J Clin Microbiol (1992) 5.91
Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev (1994) 5.77
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A (1991) 5.46
Biogeography and degree of endemicity of fluorescent Pseudomonas strains in soil. Appl Environ Microbiol (2000) 5.11
Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J Clin Microbiol (1992) 4.13
Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection. Science (2015) 2.67
Molecular correlates of host specialization in Staphylococcus aureus. PLoS One (2007) 2.41
Population genetic analysis of Borrelia burgdorferi isolates by multilocus enzyme electrophoresis. Infect Immun (1992) 2.28
Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J Clin Microbiol (2007) 2.17
Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J Clin Microbiol (1999) 2.08
Clonal associations among Staphylococcus aureus isolates from various sites of infection. Infect Immun (2001) 2.08
Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol (2004) 2.03
Molecular population genetic analysis of Staphylococcus aureus recovered from cows. J Clin Microbiol (1995) 1.98
Molecular population genetic analysis of emerged bacterial pathogens: selected insights. Emerg Infect Dis (1996) 1.94
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Biochemical and biological properties of Staphylococcal enterotoxin K. Infect Immun (2001) 1.80
Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease. Infect Immun (1996) 1.68
A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest (1993) 1.66
Correlation of acetate catabolism and growth yield in Staphylococcus aureus: implications for host-pathogen interactions. Infect Immun (2003) 1.66
The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect Immun (2005) 1.62
Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus. J Clin Microbiol (1990) 1.54
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol (2006) 1.46
Characterization of novel type C staphylococcal enterotoxins: biological and evolutionary implications. Infect Immun (1993) 1.45
Highly toxic clone of Actinobacillus actinomycetemcomitans in geographically widespread cases of juvenile periodontitis in adolescents of African origin. J Clin Microbiol (1996) 1.39
Typing of Staphylococcus aureus by PCR for DNA sequences flanked by transposon Tn916 target region and ribosomal binding site. J Clin Microbiol (1996) 1.36
Genome sequence survey identifies unique sequences and key virulence genes with unusual rates of amino Acid substitution in bovine Staphylococcus aureus. Infect Immun (2002) 1.33
Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin Infect Dis (2008) 1.22
Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J Clin Microbiol (2003) 1.18
Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves. Clin Epidemiol (2013) 1.15
Genotypic and phenotypic diversity within species of purple nonsulfur bacteria isolated from aquatic sediments. Appl Environ Microbiol (2002) 1.13
Molecular subtyping and characterization of bovine and human Streptococcus agalactiae isolates. J Clin Microbiol (2005) 1.09
Evidence of recombination in Porphyromonas gingivalis and random distribution of putative virulence markers. Infect Immun (2001) 1.02
Spatial distribution of Rhodopseudomonas palustris ecotypes on a local scale. Appl Environ Microbiol (2003) 0.96
Molecular typing and distribution of Staphylococcus aureus isolates in Eastern Canadian dairy herds. J Clin Microbiol (2004) 0.95
Epidemiology and typing of Staphylococcus aureus strains isolated from bloodstream infections. J Clin Microbiol (2004) 0.94
Genetic relationships among strains of avian Escherichia coli associated with swollen-head syndrome. Infect Immun (1990) 0.94
Genetic relationship between methicillin-sensitive and methicillin-resistant Staphylococcus aureus strains from France and from international sources: delineation of genomic groups. J Clin Microbiol (2003) 0.92
Staphylococcus aureus strains of type 95. Spread of a single clone. Epidemiol Infect (1994) 0.89
agr-dependent bacterial interference has no impact on long-term colonization of Staphylococcus aureus during persistent airway infection of cystic fibrosis patients. J Clin Microbiol (2003) 0.86
Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A. Infect Immun (1999) 0.84
Determination of clonality and relatedness of Vibrio cholerae isolates by genomic fingerprinting, using long-range repetitive element sequence-based PCR. Appl Environ Microbiol (2008) 0.81
Prevalence of Staphylococcus aureus strains in an Australian cohort, 1989-2003: evidence for the low prevalence of the toxic shock toxin and Panton-Valentine leukocidin genes. Eur J Clin Microbiol Infect Dis (2009) 0.80
Protective effect of vaginal Lactobacillus paracasei CRL 1289 against urogenital infection produced by Staphylococcus aureus in a mouse animal model. Infect Dis Obstet Gynecol (2007) 0.80
Diversity of toxic shock syndrome toxin 1-positive Staphylococcus aureus isolates. Appl Environ Microbiol (2004) 0.79
Staphylococcal toxic shock syndrome toxin-1 induces the translocation and secretion of high mobility group-1 protein from both activated T cells and monocytes. Mediators Inflamm (2008) 0.79
Phenotypes and Virulence among Staphylococcus aureus USA100, USA200, USA300, USA400, and USA600 Clonal Lineages. mSphere (2016) 0.79
Dye labelled monoclonal antibody assay for detection of Toxic Shock Syndrome Toxin -1 from Staphylococcus aureus. Iran J Microbiol (2011) 0.76
Clonal study of enterotoxin-B producing strains of Staphylococcus aureus. Epidemiol Infect (1994) 0.75
Interaction of staphylococcal toxic shock syndrome toxin-1 and enterotoxin A on T cell proliferation and TNFα secretion in human blood mononuclear cells. Can J Infect Dis (1999) 0.75
Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium. Appl Environ Microbiol (2011) 0.75
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol (1986) 24.31
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature (1983) 19.44
Genetic diversity and structure in Escherichia coli populations. Science (1980) 11.19
Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet (1978) 10.25
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40
Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol (1988) 8.18
Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med (1980) 7.85
A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet (1981) 7.69
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis (1988) 4.12
Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci U S A (1989) 3.66
Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet (1986) 2.69
Clonal diversity and host distribution in Bordetella bronchiseptica. J Bacteriol (1987) 2.59
Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins. JAMA (1985) 2.16
The Thucydides syndrome. A new hypothesis for the cause of the plague of Athens. N Engl J Med (1985) 2.04
The pertinence of the periodic selection phenomenon to prokaryote evolution. Genetics (1974) 2.00
Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome. Infect Immun (1981) 1.84
Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann Intern Med (1982) 1.73
Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. JAMA (1987) 1.69
Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits. Infect Immun (1984) 1.60
An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome. Ann Intern Med (1982) 1.48
Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing. Ann Intern Med (1982) 1.45
Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model. Infect Immun (1985) 1.30
Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome. Infect Immun (1984) 1.28
Animal studies of toxic shock syndrome. Crit Rev Microbiol (1985) 1.24
Colony immunoblot assay for the detection of staphylococcal toxic shock syndrome toxin 1 (TSST-1) with anti-TSST-1 F(ab')2 fragments. J Clin Microbiol (1989) 1.23
Toxic shock syndrome toxin 1 is encoded by a variable genetic element. Rev Infect Dis (1989) 1.20
Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus. Infect Immun (1984) 1.17
Association of toxic shock toxin-1 determinant with a heterologous insertion at multiple loci in the Staphylococcus aureus chromosome. Infect Immun (1988) 1.15
Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits. Infect Immun (1986) 1.05
Production of gamma-hemolysin and lack of production of alpha-hemolysin by Staphylococcus aureus strains associated with toxic shock syndrome. J Clin Microbiol (1988) 1.04
Microbiology of toxic shock syndrome: overview. Rev Infect Dis (1989) 1.01
Genetics and expression of toxic shock syndrome toxin 1: overview. Rev Infect Dis (1989) 0.98
Animal models for toxic shock syndrome: overview. Rev Infect Dis (1989) 0.98
Ovine-associated Staphylococcus aureus protein with immunochemical similarity to toxic shock syndrome toxin 1. J Clin Microbiol (1989) 0.97
Toxic shock syndrome and lysogeny in Staphylococcus aureus. Science (1983) 0.95
Tryptophan auxotypy associated with Staphylococcus aureus that produce toxic-shock-syndrome toxin. J Infect Dis (1985) 0.90
Genetic characterization and cloning of the toxic shock syndrome exotoxin. Surv Synth Pathol Res (1984) 0.88
Staphylococcus in toxic shock syndrome and other surgical infections. Development of new bacteriophages. Arch Surg (1983) 0.85
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol (1986) 24.31
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature (1983) 19.44
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A (1997) 15.25
Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol (1999) 11.77
Genetic diversity and structure in Escherichia coli populations. Science (1980) 11.19
Standard reference strains of Escherichia coli from natural populations. J Bacteriol (1984) 11.16
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA (1996) 9.45
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40
Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis (1990) 8.33
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med (1989) 8.01
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature (2000) 7.66
Multilocus genetic structure in natural populations of Escherichia coli. Proc Natl Acad Sci U S A (1983) 7.42
Genetic diversity and temporal variation in the E. coli population of a human host. Genetics (1981) 7.35
Exotoxins of Staphylococcus aureus. Clin Microbiol Rev (2000) 7.35
Genetic structure of populations of Legionella pneumophila. J Bacteriol (1985) 7.30
Enzyme polymorphism and genetic population structure in Escherichia coli and Shigella. J Gen Microbiol (1983) 7.28
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol (1994) 6.91
Parallel evolution of virulence in pathogenic Escherichia coli. Nature (2000) 6.25
Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect Immun (1986) 5.92
Molecular genetic relationships of the salmonellae. Appl Environ Microbiol (1996) 5.66
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A (1991) 5.46
Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci U S A (1986) 5.39
Assessment of resolution and intercenter reproducibility of results of genotyping Staphylococcus aureus by pulsed-field gel electrophoresis of SmaI macrorestriction fragments: a multicenter study. J Clin Microbiol (1998) 5.38
Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol (1987) 5.30
Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis (1994) 5.28
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA (1999) 5.25
Evidence for clonal population structure in Escherichia coli. Proc Natl Acad Sci U S A (1984) 5.08
Genetic characterization of clones of the bacterium Listeria monocytogenes causing epidemic disease. Proc Natl Acad Sci U S A (1989) 5.00
Evolutionary genetics of the proline permease gene (putP) and the control region of the proline utilization operon in populations of Salmonella and Escherichia coli. J Bacteriol (1992) 4.50
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
A population genetic framework for the study of invasive diseases caused by serotype b strains of Haemophilus influenzae. Proc Natl Acad Sci U S A (1985) 4.48
Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med (1987) 4.38
Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships. J Clin Microbiol (1993) 4.36
Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J Clin Microbiol (1992) 4.13
Geographic components of linkage disequilibrium in natural populations of Escherichia coli. Mol Biol Evol (1983) 4.11
Genetic diversity in relation to serotype in Escherichia coli. Infect Immun (1985) 4.11
Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis (1990) 4.06
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (1993) 4.06
Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis (2000) 4.01
Nucleotide polymorphism and evolution in the glyceraldehyde-3-phosphate dehydrogenase gene (gapA) in natural populations of Salmonella and Escherichia coli. Proc Natl Acad Sci U S A (1991) 3.97
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. MRSA Collaborative Study Group. J Infect Dis (1998) 3.94
Molecular genetic basis of allelic polymorphism in malate dehydrogenase (mdh) in natural populations of Escherichia coli and Salmonella enterica. Proc Natl Acad Sci U S A (1994) 3.90
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol (1990) 3.89
Salmonella reference collection B (SARB): strains of 37 serovars of subspecies I. J Gen Microbiol (1993) 3.85
Identification of a polymorphic nucleotide in oxyR specific for Mycobacterium bovis. J Clin Microbiol (1996) 3.70
Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci U S A (1989) 3.66
Management of anaerobic infections. Ann Intern Med (1975) 3.62
Genetic relationships and clonal structure of strains of Escherichia coli causing neonatal septicemia and meningitis. Infect Immun (1986) 3.57
Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis (2005) 3.54
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet (1992) 3.46
Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother (1997) 3.46
Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area. J Antimicrob Chemother (1999) 3.42
Protein polymorphism and genic heterozygosity in a wild population of the house mouse (Mus musculus). Genetics (1969) 3.40
Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 3.33
Sequence invariance of the antigen-coding central region of the phase 1 flagellar filament gene (fliC) among strains of Salmonella typhimurium. J Bacteriol (1990) 3.33
Relationship between evolutionary rate and cellular location among the Inv/Spa invasion proteins of Salmonella enterica. Proc Natl Acad Sci U S A (1995) 3.32
Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol (1992) 3.30
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill (2010) 3.15
Assignment of Staphylococcus isolates to groups by spa typing, SmaI macrorestriction analysis, and multilocus sequence typing. J Clin Microbiol (2006) 3.15
Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region. Tuber Lung Dis (1998) 3.15
Genetic diversity and relationships among strains of Escherichia coli in the intestine and those causing urinary tract infections. Prog Allergy (1983) 3.12
Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli. J Infect Dis (1975) 3.11
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother (1997) 3.05
Clonal population structure of encapsulated Haemophilus influenzae. Infect Immun (1988) 3.03
HSP60 gene sequences as universal targets for microbial species identification: studies with coagulase-negative staphylococci. J Clin Microbiol (1996) 3.03
Global regulation of Staphylococcus aureus genes by Rot. J Bacteriol (2003) 3.02
Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology (1991) 3.02
vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett (1995) 3.00
Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis (1983) 3.00
Reference collection of strains of the Salmonella typhimurium complex from natural populations. J Gen Microbiol (1991) 3.00
Genetic diversity and relationships among isolates of Rhizobium leguminosarum biovar phaseoli. Appl Environ Microbiol (1988) 2.98
Behavior and genetic variation in natural populations. Am Zool (1970) 2.86
Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis (1993) 2.84
Genetic structure of natural populations of the nitrogen-fixing bacterium Rhizobium meliloti. Appl Environ Microbiol (1990) 2.84
High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J Clin Microbiol (2006) 2.80
Recombination of Salmonella phase 1 flagellin genes generates new serovars. J Bacteriol (1990) 2.80
Genetic diversity and relationships of two pathovars of Pseudomonas syringae. J Gen Microbiol (1988) 2.80
Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill (2008) 2.78
Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun (1989) 2.77
Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist (1995) 2.75
Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Antimicrob Agents Chemother (1996) 2.75
Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet (1986) 2.69
Evolutionary genetics of the encapsulated strains of Haemophilus influenzae. Proc Natl Acad Sci U S A (1988) 2.68
The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J Biol Chem (1986) 2.63
Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2000) 2.62
Purification and characterization of group A streptococcal pyrogenic exotoxin type C. Infect Immun (1977) 2.59
Clonal diversity and host distribution in Bordetella bronchiseptica. J Bacteriol (1987) 2.59
Serious infections in adults due to group B streptococci. Clinical and serotypic characterization. Am J Med (1976) 2.58
Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother (2000) 2.55
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
Endocervical Neisseria meningitidis with meningococcemia. N Engl J Med (1971) 2.51
Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J Bacteriol (1990) 2.50
Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations. Am J Med (1978) 2.46